Aetiology and pathophysiology of chronic liver disorders
- PMID: 2081479
- DOI: 10.2165/00003495-199000403-00003
Aetiology and pathophysiology of chronic liver disorders
Abstract
The aetiology of chronic liver disease covers a wide range of congenital or acquired abnormalities of the hepatocellular biochemical network. Although our knowledge has considerably increased in recent years, the aetiology of chronic liver disease often remains obscure. Acquired irreversible disturbances of normal liver function can be mediated by hepatotrophic viruses, chemicals, chronic oxygen depletion, or interference with the immune system. Considerable progress has been made in the detection and characterisation of hepatitis B, C, and D viruses as causative agents of chronic active hepatitis. Alcohol abuse remains the predominant cause of chronic liver disease in the Western world. The targets of autoantibodies used to diagnose autoimmune diseases of the liver and primary biliary cirrhosis continue to be biochemically defined. Their significance for the aetiology of the disease, however, remains to be established. Nonparenchymal cells play an important role in the sequence of events following hepatocellular injury and ultimately leading to liver cirrhosis. They release vasoactive compounds, cytokines, and other important mediators, and participate in the modulation of the extracellular matrix that is characteristic of liver fibrosis and cirrhosis. The biochemical basis of liver cell necrosis remains poorly defined. In spite of recent progress, and the detection of some new pathogenic principles that help in the understanding of the complications of chronic liver disease such as portal hypertension, oesophagogastric variceal bleeding, portosystemic encephalopathy, ascites, and other metabolic disturbances, many questions concerning the aetiology and pathophysiology of chronic liver disease and its complications remain to be answered.
Similar articles
-
Pulmonary manifestations of chronic liver disease.Dig Dis. 1996 Mar-Apr;14(2):73-82. doi: 10.1159/000171540. Dig Dis. 1996. PMID: 8653939 Review.
-
Indications for portal pressure measurement in chronic liver disease.Scand J Gastroenterol. 2012 Sep;47(8-9):887-92. doi: 10.3109/00365521.2012.706827. Epub 2012 Jul 19. Scand J Gastroenterol. 2012. PMID: 22809270 Review.
-
The portal hypertension syndrome: etiology, classification, relevance, and animal models.Hepatol Int. 2018 Feb;12(Suppl 1):1-10. doi: 10.1007/s12072-017-9827-9. Epub 2017 Oct 24. Hepatol Int. 2018. PMID: 29064029 Review.
-
[Current status and perspectives of diagnosis and treatment of complications related to liver cirrhosis].Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):241-245. doi: 10.3760/cma.j.issn.1007-3418.2017.04.001. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28494539 Chinese.
-
[Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].Ugeskr Laeger. 2003 Jan 27;165(5):439-42. Ugeskr Laeger. 2003. PMID: 12599838 Review. Danish.
Cited by
-
Ultrasound elastography: liver.Abdom Imaging. 2015 Apr;40(4):698-708. doi: 10.1007/s00261-015-0373-4. Abdom Imaging. 2015. PMID: 25690689 Free PMC article. Review.
-
Glutamine synthetase activity and glutamate uptake in hippocampus and frontal cortex in portal hypertensive rats.World J Gastroenterol. 2009 Jun 21;15(23):2893-9. doi: 10.3748/wjg.15.2893. World J Gastroenterol. 2009. PMID: 19533812 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical